EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Antitumor and Antiproliferative Potential of Synthetic Peptides Derived from IsCT1, Associated with Cisplatin, in Squamous Cell Carcinoma of the Oral Cavity

Laertty Garcia de Sousa Cabral iD, Cyntia Silva de Oliveira iD, Vani Xavier Oliveira iD, Ellen Paim de Abreu Paulo iD, Jean-Luc Poyet iD, Durvanei Augusto Maria iD

Molecules · 2025

DOI: 10.3390/molecules30122594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Laertty Garcia de Sousa Cabral und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Development and Innovation, Butantan Institute, Sao Paulo 05585-000, Brazil. Hauptthemen laut MEDLINE: Cisplatin, Mouth Neoplasms, Antineoplastic Agents, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Coordination for the Improvement of Higher Education Personnel, CAPES—Foundation Coordination for the Improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (SCC), particularly in the oral cavity, is among the most prevalent and lethal forms of cancer globally. Current therapeutic strategies, predominantly involving cisplatin, face challenges like chemoresistance and toxicity to normal cells, justifying the exploration of new approaches. This study evaluates the antitumor, antiproliferative, and immunomodulatory potential of a synthetic peptide derived from IsCT1 (Isalo scorpion cytotoxic peptide), named AC-AFPK-IsCT1, in combination with cisplatin in oral squamous cell carcinoma cellular models. Tumor and normal cells were treated with varying concentrations of cisplatin and peptide, and the cytotoxicity was measured through an MTT assay, while apoptosis and cell cycle alterations were assessed via flow cytometry. Interestingly, the combination of AC-AFPK-IsCT1 with cisplatin exhibited higher specificity for tumor cells, significantly reducing IC50 values compared to cisplatin used as a single agent. Moreover, the combination treatment induced pronounced S-phase cell cycle arrest and enhanced apoptotic activity, evidenced by the upregulation of caspase-3, caspase-8, and p53, while maintaining low toxicity in normal fibroblast cells. The peptide also modulated the mitochondrial membrane potential, further contributing to the activation of intrinsic apoptotic pathways. The data suggest that AC-AFPK-IsCT1 potentiates the antitumor effects of cisplatin by engaging both intrinsic and extrinsic apoptotic pathways while preserving normal cell viability. These findings underscore the potential of combining cisplatin with AC-AFPK-IsCT1 as a promising therapeutic strategy for improving the efficacy of chemotherapy in SCC, reducing systemic toxicity, and overcoming chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinMouth NeoplasmsAntineoplastic AgentsPeptidesCarcinoma, Squamous CellSquamous Cell Carcinoma of Head and NeckScorpion VenomsHumansCell ProliferationCell Line, TumorApoptosisMembrane Potential, MitochondrialAnimals

Stichwörter der Autor:innen

anticancer peptideapoptosissquamous cell carcinomasynthetic peptidetongue cancer

Substanzen

CisplatinAntineoplastic AgentsPeptidesScorpion Venoms

Autor:innen und Institutionen

  • Laboratory of Development and Innovation, Butantan Institute, Sao Paulo 05585-000, Brazil.
  • Faculty of Medicine, University of Sao Paulo (FMUSP), Sao Paulo 05508-220, Brazil.
  • Department of Molecular Biology, Federal University of Sao Paulo (UNIFESP) Sao Paulo 09913-030, Brazil.
  • Center for Natural and Human Sciences, Federal University of ABC, Santo Andre 09210-580, Brazil.
  • INSERM UMRS1342-CNRS EMR8000, Institut De Recherche Saint-Louis, Hôpital Saint-Louis, 75010 Paris, France.
  • Université Paris Cité, 75006 Paris, France.

ORCID-Profile: Laertty Garcia de Sousa Cabral, Cyntia Silva de Oliveira, Vani Xavier Oliveira, Ellen Paim de Abreu Paulo, Jean-Luc Poyet, Durvanei Augusto Maria

Förderung

  • Foundation Coordination for the Improvement of Higher Education Personnel
  • CAPES—Foundation Coordination for the Improvement of Higher Education Personnel

Zitieren

APA

Cabral, L. G. S., de Oliveira, C. S., Oliveira, V. X., de Abreu Paulo, E. P., Poyet, J. L., & Maria, D. A. (2025). Evaluation of the Antitumor and Antiproliferative Potential of Synthetic Peptides Derived from IsCT1, Associated with Cisplatin, in Squamous Cell Carcinoma of the Oral Cavity. Molecules. https://doi.org/10.3390/molecules30122594

Vancouver

Cabral LGS, de Oliveira CS, Oliveira VX, de Abreu Paulo EP, Poyet JL, Maria DA. Evaluation of the Antitumor and Antiproliferative Potential of Synthetic Peptides Derived from IsCT1, Associated with Cisplatin, in Squamous Cell Carcinoma of the Oral Cavity. Molecules. 2025. doi:10.3390/molecules30122594

BibTeX
@article{Cabral2025,
  author = {Cabral, Laertty Garcia de Sousa and de Oliveira, Cyntia Silva and Oliveira, Vani Xavier and de Abreu Paulo, Ellen Paim and Poyet, Jean-Luc and Maria, Durvanei Augusto},
  title = {Evaluation of the Antitumor and Antiproliferative Potential of Synthetic Peptides Derived from IsCT1, Associated with Cisplatin, in Squamous Cell Carcinoma of the Oral Cavity},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30122594}
}
Kostenlos starten →